Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in a ...

• Establishing pharmacologically relevant exposure levels and engagement are two key steps in target validation. • There is a need for better biomarkers to objectively measure biological states and ...

Engitix is a biotechnology company focused on discovering and developing novel therapeutics by leveraging its proprietary extracellular matrix platform. By using human tissue-derived ECM Platform ...

AI-Driven Drug Discovery Fuels Explosive Demand for Wet-Lab Validation, Creating New Opportunities for Specialized Autoimmune CROs The global population affected by autoimmune diseases continues to ...

Despite rapid advances in AI, many drug discovery models still struggle to translate computational predictions into clinical ...

Japan’s pharmaceutical sector is gradually reorienting from deep, validation-led development towards execution-driven ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the next-generation of Lens, its pioneering agentic AI ...

Launch of TechBio firm, Lucera, brings decision intelligence to drug development, making it more predictable, more evidence-grounded, and more ...